BPC-157 and Naltrexone Interaction

Synergistic
Mechanism-based 50% confidence

BPC-157 and Naltrexone have a synergistic interaction with 50% confidence. BPC-157 reduces inflammation while Naltrexone promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Naltrexone

Opioid Antagonist | Low-Dose Anti-Inflammatory & Immune Modulation

At low doses (1-4.5 mg), naltrexone produces a brief nocturnal blockade of opioid receptors that lasts approximately 4-6 hours.

Half-life: ~4 hours Typical dose: 1.5-4.5 mg/day (LDN) immune, longevity
opioid receptor hepatotoxic
View full profile

Combined Organ Load

Blood Vessels
low

Frequently Asked Questions

Can I take BPC-157 with Naltrexone?

Yes, BPC-157 and Naltrexone can generally be taken together. BPC-157 reduces inflammation while Naltrexone promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.

Is BPC-157 and Naltrexone safe together?

Based on pharmacological analysis, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between BPC-157 and Naltrexone?

BPC-157 reduces inflammation while Naltrexone promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.

How should I time BPC-157 and Naltrexone?

BPC-157 has a half-life of <30 minutes and Naltrexone has a half-life of ~4 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Naltrexone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.